lipid x has been researched along with galactosamine in 3 studies
| Studies (lipid x) | Trials (lipid x) | Recent Studies (post-2010) (lipid x) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
|---|---|---|---|---|---|
| 67 | 0 | 6 | 3,542 | 7 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hildebrandt, J; Lam, C; Liehl, E; Proctor, RA; Rosenwirth, B; Schütze, E; Stütz, P | 1 |
| Basalka, E; Lam, C; Schütze, E; Walzl, H | 2 |
3 other study(ies) available for lipid x and galactosamine
| Article | Year |
|---|---|
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Dinoprostone; Disaccharides; Dose-Response Relationship, Drug; Endotoxins; Female; Galactosamine; Glycolipids; Humans; In Vitro Techniques; Interleukin-1; Limulus Test; Macrophages; Mice; Mice, Inbred Strains; Monocytes; Neutrophils; Pyrogens; Rabbits; Shwartzman Phenomenon; Sugar Phosphates; Superoxides; Tumor Necrosis Factor-alpha | 1991 |
Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
Topics: Animals; Cell Aggregation; Galactosamine; Glucuronidase; Glycolipids; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Shock, Septic; Superoxides | 1987 |
Inhibition of lipopolysaccharide-mediated activation of neutrophils with monosaccharide derivatives of lipid A.
Topics: Animals; Galactosamine; Glycolipids; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Neutrophils; Oxygen | 1987 |